Seaport Therapeutics SPTX
NASDAQ SPTX
$19.12 -0.86 (-4.30%)
At close: Nov 16, 2026 · 4:00 PM EST

Seaport Therapeutics (SPTX) EBIT (2025 - 2026)

Updated

Seaport Therapeutics' EBIT was -$30.35 million in Q3 2026, compared with -$25.44 million a year earlier.

Analysis

Seaport Therapeutics (SPTX) EBIT (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Seaport Therapeutics' EBIT was -$150.9 million through Sep 30, 2026; for FY2025, it came in at -$87.29 million.

  • In earlier years, EBIT was -$52.42 million in FY2024.
  • Quarterly EBIT has moved between -$65.81 million (Q2 2026) and -$16.19 million (Q1 2025) over five years.
  • Per Business Quant data, SPTX's EBIT in the three quarters before Q3 2026 was -$65.81 million (Q2 2026), -$27.54 million (Q1 2026) and -$27.2 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 8.41 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 6.18 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 6.27 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.56 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 4.39 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.71 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 3.46 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 5.47 Bn
10 Seaport Therapeutics 1.03 Bn 63.31 Mn - -30.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -30.35 Mn
Jun 30, 2026 -65.81 Mn
Mar 31, 2026 -27.54 Mn
Dec 31, 2025 -27.20 Mn
Sep 30, 2025 -25.44 Mn
Jun 30, 2025 -18.47 Mn
Mar 31, 2025 -16.19 Mn
API Access

Seaport Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=SPTX&period=max&api_key=YOUR_API_KEY